
In a prospective study, 121 patients with spontaneous rupture of the membranes of greater than 6 hours duration and unfavourable Bishop-Score (less than 6) were stimulated with 3 mg vaginal prostaglandin-E2-tablets. All patients started labour. Only one patient had a hyperstimulation which was corrected with betamimetics. There were no systemic side effects. Almost 90% of the women delivered on the first day. The rate of the Caesarean sections was low. There was no case of intraamniotic infection; the foetal outcome was good. In conclusion, vaginal prostaglandin-E2-tablets are safe to use in spontaneous rupture of the membranes.
Administration, Intravaginal, Dose-Response Relationship, Drug, Cesarean Section, Pregnancy, Infant, Newborn, Humans, Female, Premature Rupture of Fetal Membranes, Labor, Induced, Fetal Monitoring, Dinoprostone, Drug Administration Schedule
Administration, Intravaginal, Dose-Response Relationship, Drug, Cesarean Section, Pregnancy, Infant, Newborn, Humans, Female, Premature Rupture of Fetal Membranes, Labor, Induced, Fetal Monitoring, Dinoprostone, Drug Administration Schedule
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
